Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

Por Aleskandarany, Mohammed A, Green, Andrew R, Benhasouna, Ahmed A, Barros, Fabricio F, Neal, Keith, Reis-Filho, Jorge S, Ellis, Ian O, Rakha, Emad A
Publicado em 2012

Biological and clinical significance of PARP1 protein expression in breast cancer

Por Green, Andrew R., Caracappa, Daniela, Benhasouna, Ahmed A., Alshareeda, Alaa, Nolan, Christopher C., Macmillan, R. Douglas, Madhusudan, Srinivasan, Ellis, Ian O., Rakha, Emad A.
Publicado no Breast Cancer Res Treat (2014)